This Drug Should Be Doing Triple Digits Weekly Minimum!!

Quote

anonymous

Guest
Deeply concerned about the professionalism of this sales force and the lack of experience with the New Hires. What a waste of money and resources. Should the Trial be lost, Vascepa will go down as one of if not the worst Launches in History.
 






anonymous said:
Deeply concerned about the professionalism of this sales force and the lack of experience with the New Hires. What a waste of money and resources. Should the Trial be lost, Vascepa will go down as one of if not the worst Launches in History.
Click to expand...


What would you suggest we do when the patient gets to pharmacy to find out vascepa is too expensive for them or when the office gets a PA that says the patient must take an omega 3 or fibrate instead of vascepa? Go complain to the managed care team. Alot of complaints coming out about cost and coverage. How long can we deflect this issue til they just give up? Still a sales fault? Please.
 






anonymous said:
What would you suggest we do when the patient gets to pharmacy to find out vascepa is too expensive for them or when the office gets a PA that says the patient must take an omega 3 or fibrate instead of vascepa? Go complain to the managed care team. Alot of complaints coming out about cost and coverage. How long can we deflect this issue til they just give up? Still a sales fault? Please.
Click to expand...

This is exactly the reason Big Pharma needs to get Vascepa in their hands! I hope they do so soon because this is becoming very depressing.
 






anonymous said:
What would you suggest we do when the patient gets to pharmacy to find out vascepa is too expensive for them or when the office gets a PA that says the patient must take an omega 3 or fibrate instead of vascepa? Go complain to the managed care team. Alot of complaints coming out about cost and coverage. How long can we deflect this issue til they just give up? Still a sales fault? Please.
Click to expand...
You are no longer selling fish oil, you are selling outcomes. Yes the managed care people need to improve access, and now they have the ammo to do so. Similarly, we can help facilitate better access by driving demand; docs are more willing to fight for proven cardiovascular benefits than for drugs in many other disease states and every PA that is pushed forward will help. It’s not easy but if it were simple they wouldn’t need us.
 












anonymous said:
You are no longer selling fish oil, you are selling outcomes. Yes the managed care people need to improve access, and now they have the ammo to do so. Similarly, we can help facilitate better access by driving demand; docs are more willing to fight for proven cardiovascular benefits than for drugs in many other disease states and every PA that is pushed forward will help. It’s not easy but if it were simple they wouldn’t need us.
Click to expand...


And that is absolutely the daily battle we encounter. But we continue to lose scripts due to PA requirements and cost at the pharmacy level, mostly for medicare patients. So when someone gets on here and complains that our numbers aren't popping, realisitcally step back and look at why. The drug is outcomes driven, yes. But if a patient gets to the pharmacy and cannot afford it, there is little we can do to help alleviate that. It becomes a managed care thing, not because we haven't done our job. Need all cogs in the machine turning for us to be successful.
 






anonymous said:
And that is absolutely the daily battle we encounter. But we continue to lose scripts due to PA requirements and cost at the pharmacy level, mostly for medicare patients. So when someone gets on here and complains that our numbers aren't popping, realisitcally step back and look at why. The drug is outcomes driven, yes. But if a patient gets to the pharmacy and cannot afford it, there is little we can do to help alleviate that. It becomes a managed care thing, not because we haven't done our job. Need all cogs in the machine turning for us to be successful.
Click to expand...
I hear you; the best bang for the buck is to focus on the commercial book of business until such time as Medicare plans capitulate over. Plenty of opportunity here and yes you are correct in saying that docs (especially primary care) will turn off if every rx results in a PA or unacceptable cost to the patient. Cards are more willing to do PAs so the Medicare book of business is more viable there, for pcps focus on the commercial patient.
 






anonymous said:
I hear you; the best bang for the buck is to focus on the commercial book of business until such time as Medicare plans capitulate over. Plenty of opportunity here and yes you are correct in saying that docs (especially primary care) will turn off if every rx results in a PA or unacceptable cost to the patient. Cards are more willing to do PAs so the Medicare book of business is more viable there, for pcps focus on the commercial patient.
Click to expand...


You're so right about all of this. Especially right now.
 






anonymous said:
Doctors are clearly no longer impressed or interested. The pizzazzzzzz is no more. Faded rather quickly
Click to expand...
And that is the fault of a bad sales team. Newbie hires who don’t have a clue, old boomer big pharma managers trying to push some papers while they milk the last few years until retirement, and the worst: promoting reps from within to become managers. The only reason they were working as reps for this company is that no real pharma companies would hire them. Now you bump their clueless unprofessional asses to manager and the whole system crashes. What a mess!!!
 
























anonymous said:
I hear you; the best bang for the buck is to focus on the commercial book of business until such time as Medicare plans capitulate over. Plenty of opportunity here and yes you are correct in saying that docs (especially primary care) will turn off if every rx results in a PA or unacceptable cost to the patient. Cards are more willing to do PAs so the Medicare book of business is more viable there, for pcps focus on the commercial patient.
Click to expand...

Does this bode well for the new CV openings?
 












  • Woody   Feb 04, 2020 at 01:50: PM
Rome was NOT built in a day. I launched Lipitor and Crestor, and it takes time, and a don't let them off the hook..attitude. Keep it up and as more CD's write the drug it will be selling well in about 1 year. It looks like many of you are crybabies. That will get you nowhere. Know your product and the others inside and out. Go for it!
 






Woody said:
Rome was NOT built in a day. I launched Lipitor and Crestor, and it takes time, and a don't let them off the hook..attitude. Keep it up and as more CD's write the drug it will be selling well in about 1 year. It looks like many of you are crybabies. That will get you nowhere. Know your product and the others inside and out. Go for it!
Click to expand...


YOU LAUCHED LIPITOR AT PARKE DAVIS IN 1996 AND WORKING HERE ? A DESPERATE BOOMER FOR SURE
 












anonymous said:
You are no longer selling fish oil, you are selling outcomes. Yes the managed care people need to improve access, and now they have the ammo to do so. Similarly, we can help facilitate better access by driving demand; docs are more willing to fight for proven cardiovascular benefits than for drugs in many other disease states and every PA that is pushed forward will help. It’s not easy but if it were simple they wouldn’t need us.
Click to expand...

Well written! I am cheering for you guys.
 


















Top Bottom
Back
Quote